TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
94,462
|
78,910
|
77,756 |
Financial expenses |
318
|
309
|
177 |
Earnings before taxes |
16,016
|
13,883
|
10,959 |
EBITDA |
18,135
|
17,387
|
15,221 |
Total assets |
95,734
|
81,468
|
76,216 |
Current assets |
33,846
|
24,308
|
18,657 |
Current liabilities |
19,793
|
18,680
|
19,819 |
Equity capital |
75,249
|
62,237
|
55,841 |
- share capital |
17,854
|
17,762
|
19,328 |
Employees (average) |
24
|
21
|
23 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
78.6%
|
76.4%
|
73.3% |
Turnover per employee |
3,936
|
3,758
|
3,381 |
Profit as a percentage of turnover |
17.0%
|
17.6%
|
14.1% |
Return on assets (ROA) |
17.1%
|
17.4%
|
14.6% |
Current ratio |
171.0%
|
130.1%
|
94.1% |
Return on equity (ROE) |
21.3%
|
22.3%
|
19.6% |
Change turnover |
15,146
|
7,452
|
11,893 |
Change turnover % |
19%
|
10%
|
18% |
Chg. No. of employees |
3
|
-2
|
4 |
Chg. No. of employees % |
14%
|
-9%
|
21% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.